Aemetis Inc (NASDAQ:AMTX) received a $2.00 price objective from research analysts at FBR & Co in a report released on Tuesday, May 16th. The firm presently has a “hold” rating on the specialty chemicals company’s stock. FBR & Co’s price target points to a potential upside of 25.00% from the stock’s current price.
Separately, Zacks Investment Research downgraded Aemetis from a “buy” rating to a “hold” rating in a research report on Monday, January 23rd.
A hedge fund recently raised its stake in Aemetis stock. Geneva Advisors LLC boosted its position in Aemetis Inc (NASDAQ:AMTX) by 2.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,511,631 shares of the specialty chemicals company’s stock after buying an additional 32,400 shares during the period. Geneva Advisors LLC owned 7.67% of Aemetis worth $1,950,000 as of its most recent SEC filing. 18.62% of the stock is owned by institutional investors. Aemetis Company Profile